Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · View financials
Decision snapshot: ITCI stock price vs GBX: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at GBX's multiple
Needs GBX P/S.
Implied fair value · at ITCI's multiple
Needs ITCI P/S.
Metric by metric
Live quote
Price unavailable
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ITCI FY 2024 (ended Dec 31, 2024) · GBX FY 2025 (ended Aug 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Intra-Cellular Therapies, Inc. · implied price per share
Bear
-$2.92
Base
-$3.43
Bull
-$3.95
THE GREENBRIER COMPANIES, INC. · implied price per share
Bear
$40.55
Base
$47.71
Bull
$54.87
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.19x
1.14x
Net debt / EBITDA
Leverage against operating earnings
9.34x
3.12x
Cash and equivalents
Liquid reserves on the balance sheet
$904.35M
$306.10M
Total debt
Interest-bearing obligations outstanding
$216.02M
$1.75B
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
SUPERNUS PHARMACEUTICALS, INC.
ITCI vs SUPN
ACADIA PHARMACEUTICALS INC
ITCI vs ACAD
Vanda Pharmaceuticals Inc.
ITCI vs VNDA
Sage Therapeutics, Inc.
ITCI vs SAGE
TRINITY INDUSTRIES INC
ITCI vs TRN
WESTINGHOUSE AIR BRAKE TECHNOLOGIES CORP
ITCI vs WAB
HELIOS TECHNOLOGIES, INC.
ITCI vs HLIO
SMITH A O CORP
ITCI vs AOS
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
